Cargando…

The Relationship between Dyslipidemia and Acute Axonal Function in Type 2 Diabetes Mellitus In Vivo

OBJECTIVES: Diabetic peripheral neuropathy (DPN) is a common and debilitating complication of diabetes mellitus. Treatment largely consists of symptom alleviation and there is a need to identify therapeutic targets for prevention and treatment of DPN. The objective of this study was to utilise novel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwai, Natalie C. G., Nigole, William, Poynten, Ann M., Brown, Christopher, Krishnan, Arun V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831805/ https://www.ncbi.nlm.nih.gov/pubmed/27078166 http://dx.doi.org/10.1371/journal.pone.0153389

Ejemplares similares

Effects of Axonal Ion Channel Dysfunction on Quality of Life in Type 2 Diabetes
por: Kwai, Natalie C.G., et al.
Publicado: (2013)

Chronic Kidney Disease Has No Impact on Tear Film Substance P Concentration in Type 2 Diabetes
por: Asiedu, Kofi, et al.
Publicado: (2023)

Diagnostic accuracy of nerve ultrasonography for the detection of peripheral neuropathy in type 2 diabetes
por: Dhanapalaratnam, Roshan, et al.
Publicado: (2022)

Progressive Axonal Dysfunction Precedes Development of Neuropathy in Type 2 Diabetes
por: Sung, Jia-Ying, et al.
Publicado: (2012)

Impact of Chronic Kidney Disease on Corneal Neuroimmune Features in Type 2 Diabetes
por: Asiedu, Kofi, et al.
Publicado: (2022)

Dyslipidemia in Pediatric Type 2 Diabetes Mellitus
por: Sunil, Bhuvana, et al.
Publicado: (2020)

Comparison of the relationships of alcoholic and nonalcoholic fatty liver with hypertension, diabetes mellitus, and dyslipidemia
por: Toshikuni, Nobuyuki, et al.
Publicado: (2013)

Relationship between dyslipidemia and diabetic retinopathy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
por: Li, Zhaoping, et al.
Publicado: (2023)

Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia
por: Zaman Huri, Hasniza, et al.
Publicado: (2013)

The prevalence of dyslipidemia in patients with diabetes mellitus of ayurveda Hospital
por: Dixit, Amit Kumar, et al.
Publicado: (2014)

Novel Molecules in Diabetes Mellitus, Dyslipidemia and Cardiovascular Disease
por: Vesa, Cosmin Mihai, et al.
Publicado: (2023)

Correlation study on the relationship between dyslipidemia and carotid intima-media thickness in patients with diabetes mellitus
por: Guo, Hong-jiang, et al.
Publicado: (2023)

Peripheral nerve morphology and intraneural blood flow in chronic kidney disease with and without diabetes
por: Issar, Tushar, et al.
Publicado: (2022)

The Role of Dyslipidemia Control in the Progression of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus
por: Chatziralli, Irini P.
Publicado: (2017)

Atherogenic dyslipidemia and diabetes mellitus: what’s new in the management arena?
por: Kumar, Ajoy, et al.
Publicado: (2010)

Implications of serum paraoxonase activity in obesity, diabetes mellitus, and dyslipidemia
por: Kota, Sunil K., et al.
Publicado: (2013)

Investigating the biochemical association of gestational diabetes mellitus with dyslipidemia and hemoglobin
por: Akash, Muhammad Sajid Hamid, et al.
Publicado: (2023)

Severe dyslipidemia associated with diabetic ketoacidosis in newly diagnosed female of type 1 diabetes mellitus
por: Chreitah, Ahmad, et al.
Publicado: (2021)

Acceptance and Effect of Continuous Glucose Monitoring on Discharge From Hospital in Patients With Type 2 Diabetes: Open-label, Prospective, Controlled Study
por: Depczynski, Barbara, et al.
Publicado: (2022)

HbA1c – A predictor of dyslipidemia in type 2 Diabetes Mellitus
por: Kidwai, Saera Suhail, et al.
Publicado: (2020)

Prevalence and pattern of dyslipidemia in patients with type 2 diabetes mellitus in Zaria, Northwestern Nigeria
por: Bello-Ovosi, Beatrice Ohunene, et al.
Publicado: (2019)

Prevalence of Dyslipidemia in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study
por: Al Ghadeer, Hussain A, et al.
Publicado: (2021)

Lotus leaf alleviates hyperglycemia and dyslipidemia in animal model of diabetes mellitus
por: Kim, Ah-Rong, et al.
Publicado: (2013)

Pre-Conception Dyslipidemia Is Associated with Development of Preeclampsia and Gestational Diabetes Mellitus
por: Baumfeld, Yael, et al.
Publicado: (2015)

Association of Dyslipidemia with Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients: A Hospital-Based Study
por: Ezhilvendhan, Kalaimamani, et al.
Publicado: (2021)

Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus
por: Dejenie, Tadesse Asmamaw, et al.
Publicado: (2023)

Continuous glucose monitoring to assess glucose variability in type 3c diabetes
por: Lee, Victoria T. Y., et al.
Publicado: (2022)

Diabetes Dyslipidemia
por: Schofield, Jonathan D., et al.
Publicado: (2016)

Effect of Atorvastatin on Growth Differentiation Factor-15 in Patients with Type 2 Diabetes Mellitus and Dyslipidemia
por: Kim, Ji Min, et al.
Publicado: (2016)

LDLR C1725T Gene Polymorphism Frequency in Type 2 Diabetes Mellitus Patients With Dyslipidemia
por: Eroglu, Zuhal, et al.
Publicado: (2016)

Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus
por: Kong, Sung Hye, et al.
Publicado: (2017)

Prevalence and Associated Factors of Dyslipidemia Among Adults with Type 2 Diabetes Mellitus in Saudi Arabia
por: Alzaheb, Riyadh A, et al.
Publicado: (2020)

Circulating lymphocytes and monocytes transcriptomic analysis of patients with type 2 diabetes mellitus, dyslipidemia and periodontitis
por: Corbi, Sâmia C. T., et al.
Publicado: (2020)

Dyslipidemia among Patients with Type 2 Diabetes Mellitus Visiting a Tertiary Care Centre
por: Khadka, Bikram, et al.
Publicado: (2023)

Correction: Pre-Conception Dyslipidemia Is Associated with Development of Preeclampsia and Gestational Diabetes Mellitus
por: Baumfeld, Yael, et al.
Publicado: (2015)

Cumulative Effects of Hypertension, Dyslipidemia, and Chronic Kidney Disease on Carotid Atherosclerosis in Chinese Patients with Type 2 Diabetes Mellitus
por: Yuan, Chuang, et al.
Publicado: (2014)

The role of elevated alanine aminotransferase (ALT), FasL and atherogenic dyslipidemia in type II diabetes mellitus
por: Mahran, Howayda N., et al.
Publicado: (2016)

Comparison of the Efficacy of Rosuvastatin 5 mg and 10 mg in Patients of Type 2 Diabetes Mellitus With Dyslipidemia
por: Aleem, Mudassar, et al.
Publicado: (2022)

Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study
por: Kaze, Arnaud D., et al.
Publicado: (2021)

Association of healthy lifestyles on the risk of hypertension, type 2 diabetes mellitus, and their comorbidity among subjects with dyslipidemia
por: Hu, Peng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g49prg2s67rue231nc5v4446ft